Echt, Netherlands

Dennis Heemskerk

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Ad Schinveld, NL (2008)
  • Schinveld, NL (2009 - 2013)
  • Echt, NL (2015 - 2019)

Company Filing History:


Years Active: 2008-2019

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Dennis Heemskerk

Introduction

Dennis Heemskerk, a prominent inventor located in Echt, Netherlands, has contributed significantly to the field of pharmaceutical development with a total of nine patents to his name. His innovations primarily focus on the synthesis of statin precursors, which are essential in manufacturing important medications.

Latest Patents

Among his latest inventions is a process for preparing a statin precursor. This invention involves a meticulous process with several steps, starting with the reaction of a hydroxy-pyrimidine-carbonitrile with an organic sulfonyl halide to form a sulfonate-pyrimidine-carbonitrile. This is followed by the reaction of the sulfonate compound with N-methylmethane sulfonamide, yielding a pyrimidinyl-sulfonamide. Optionally, a third reaction step can take place, where the pyrimidinyl-sulfonamide is reacted with a reducing agent, all conducted in toluene as the main solvent.

Another significant patent from Heemskerk is related to the preparation of a thioprecursor for statins. This process outlines the creation of a precursor specifically for the synthesis of hexanoic acid-derived statins, which plays a critical role in the manufacture of medicaments.

Career Highlights

Dennis has worked at reputable companies such as DSM Sinochem Pharmaceuticals Netherlands B.V. and DSM IP Assets B.V. His experience in these organizations has equipped him with extensive knowledge and expertise in pharmaceutical sciences and the development of innovative processes.

Collaborations

Throughout his career, Heemskerk has collaborated with notable professionals in the industry, including Ben De Lange and Karin Henderika Maria Bessembinder. These partnerships have fostered an environment of creativity and innovation within the pharmaceutical sector.

Conclusion

With a robust portfolio of patents and a dedication to medicinal chemistry, Dennis Heemskerk stands out as a significant inventor in the pharmaceutical industry. His work on statin precursors not only showcases his inventive capabilities but also contributes to advances in the treatment of various health conditions. His ongoing efforts reinforce the importance of innovation in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…